What's new in Interventional Cardiology

A 69-year-old woman with severe symptomatic aortic stenosis (NYHA III) and complex comorbidities, including three-vessel coronary artery disease, advanced COPD, and peripheral artery disease, presents with progressive dyspnoea despite recent PCI. How would you treat this patient?

Eugene Braunwald, whose work reshaped cardiovascular medicine into the rigorous, evidence-based discipline we know today, leaves behind an extraordinary scientific legacy. He transformed how we think about the heart: not just as an organ to observe, but as a system to understand, measure, and treat through...

When standard catheters and wires repeatedly fail to cross a severely stenotic aortic valve, a simple modification of readily available equipment may provide a solution.

This step-by-step tutorial explains how to create and use a self-made steerable catheter system to facilitate valve crossing in complex TAVI anatomies.

A 68-year-old woman presents with symptomatic aortic stenosis and tricuspid valve anatomy, with no significant comorbidities and no evidence of coronary artery disease. Given her strong preference for a less invasive strategy, the Heart Team considers a transcatheter approach.
How would you treat this patient—and in case...

Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

During the first Late-Breaking Trial session of the 2026 ACC Congress held in New Orleans, Saibal Kar, principal investigator of the CHAMPION-AF trial, presented the 3-year results of this groundbreaking study, which were simultaneously published in the NEJM (DOI: 10.1056/NEJMoa2517213).

Discriminating between coronary calcification and thrombus in acute settings remains a diagnostic challenge with significant implications for interventional decision-making.

Ali Nazmi Calik provides his take on the results of the OPTIMAL trial presented by Luca Testa at ACC.26 in New Orleans.

Alex Sticchi interviews Erwan Donal on the 2-year outcomes of the TRI-FR randomised trial evaluating transcatheter tricuspid edge-to-edge repair (T-TEER) versus medical therapy alone, as presented at ACC.26 in New Orleans.